Norihiko Takemoto

DOCK2 is involved in the host genetics and biology of severe COVID-19

Ho Namkoong, Ryuya Edahiro, Tomomi Takano et al. · Nature · 2022 · 97 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Tumor Markers CEA, CA19-9 and CA125 in Monitoring of Response to Systemic Chemotherapy in Patients with Advanced Gastric Cancer

Takekazu Yamao, S. Kai, Akira Kazami et al. · Japanese Journal of Clinical Oncology · 1999 · 95 citations · Full text

Medicine, Oncology, Pathology +17

Prognostic Factors of Peripheral Facial Palsy

Norihiko Takemoto, Arata Horii, Yoshiharu Sakata et al. · Otology & Neurotology · 2011 · 76 citations

Medicine, Neurology, Early Detection +14

Circulating tumor <scp>HPV DNA</scp> complements <scp>PET‐CT</scp> in guiding management after radiotherapy in <scp>HPV</scp>‐related squamous cell carcinoma of the head and neck

Hidenori Tanaka, Norihiko Takemoto, Masafumi Horie et al. · International Journal of Cancer · 2020 · 64 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Prognostic significance of body mass index before treatment for head and neck cancer

Yukinori Takenaka, Norihiko Takemoto, Susumu Nakahara et al. · Head & Neck · 2014 · 56 citations · Full text

Medicine, Nutritional Sciences, Oncology +14